| ABYEX | RNWBX | ABYEX / RNWBX | |
| Total Expense Ratio | 1.00 | 1.67 | 60% |
| Annual Report Gross Expense Ratio | 1.40 | 1.67 | 84% |
| Fund Existence | 14 years | 23 years | - |
| Gain YTD | 14.636 | 18.246 | 80% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 143M | 71.4B | 0% |
| Annual Yield % from dividends | 5.20 | 0.13 | 4,145% |
| Returns for 1 year | 17.31 | 14.06 | 123% |
| Returns for 3 years | 51.65 | 40.53 | 127% |
| Returns for 5 years | 29.32 | 21.44 | 137% |
| Returns for 10 years | 70.19 | 84.15 | 83% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AGRYX | 144.00 | 0.30 | +0.21% |
| AB Growth Advisor | |||
| BADEX | 11.02 | 0.02 | +0.18% |
| BlackRock Defensive Advantage EM Inv A | |||
| SHSKX | 65.13 | N/A | N/A |
| BlackRock Health Sciences Opps K | |||
| ANTUX | 10.39 | N/A | N/A |
| American Century Non-US IntrsVal Inv | |||
| DSMLX | 67.40 | -0.15 | -0.22% |
| Touchstone Large Company Growth Instl | |||